Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites

Clinical trial NCT00326885 · COMPLETED

Trial details

NCT number: NCT00326885
Sponsor: Neovii Biotech
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Ascites

Start date: 2006-06-01
Primary completion: 2009-12-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.